1. Home
  2. MEC vs SLN Comparison

MEC vs SLN Comparison

Compare MEC & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEC
  • SLN
  • Stock Information
  • Founded
  • MEC 1945
  • SLN 1994
  • Country
  • MEC United States
  • SLN United Kingdom
  • Employees
  • MEC N/A
  • SLN N/A
  • Industry
  • MEC Industrial Specialties
  • SLN Biotechnology: Pharmaceutical Preparations
  • Sector
  • MEC Industrials
  • SLN Health Care
  • Exchange
  • MEC Nasdaq
  • SLN Nasdaq
  • Market Cap
  • MEC 319.0M
  • SLN 273.9M
  • IPO Year
  • MEC 2019
  • SLN N/A
  • Fundamental
  • Price
  • MEC $16.12
  • SLN $6.34
  • Analyst Decision
  • MEC Strong Buy
  • SLN Buy
  • Analyst Count
  • MEC 3
  • SLN 5
  • Target Price
  • MEC $21.33
  • SLN $32.60
  • AVG Volume (30 Days)
  • MEC 97.0K
  • SLN 90.6K
  • Earning Date
  • MEC 08-05-2025
  • SLN 08-14-2025
  • Dividend Yield
  • MEC N/A
  • SLN N/A
  • EPS Growth
  • MEC 160.08
  • SLN N/A
  • EPS
  • MEC 1.08
  • SLN N/A
  • Revenue
  • MEC $555,914,000.00
  • SLN $27,701,000.00
  • Revenue This Year
  • MEC $2.00
  • SLN N/A
  • Revenue Next Year
  • MEC $11.49
  • SLN N/A
  • P/E Ratio
  • MEC $14.56
  • SLN N/A
  • Revenue Growth
  • MEC N/A
  • SLN N/A
  • 52 Week Low
  • MEC $11.72
  • SLN $1.97
  • 52 Week High
  • MEC $23.02
  • SLN $21.99
  • Technical
  • Relative Strength Index (RSI)
  • MEC 55.22
  • SLN 58.73
  • Support Level
  • MEC $15.12
  • SLN $5.76
  • Resistance Level
  • MEC $16.08
  • SLN $6.40
  • Average True Range (ATR)
  • MEC 0.53
  • SLN 0.42
  • MACD
  • MEC -0.06
  • SLN -0.03
  • Stochastic Oscillator
  • MEC 60.60
  • SLN 63.93

About MEC Mayville Engineering Company Inc.

Mayville Engineering Co Inc is involved in a manufacturing partner providing a full suite of manufacturing solutions from concept to production, including design, prototyping and tooling, fabrication, aluminum extrusion, coating, assembly and aftermarket components. Its customers operate in diverse end markets, including heavy- and medium-duty commercial vehicles, construction, power sports, agriculture, military, and other end markets. Its services comprise stamping, shearing, fiber laser cutting, forming, drilling, tapping, grinding, tube bending, machining, welding, assembly and logistic services.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: